Author: Dr. David Lowemann

Study: Anti-Amyloid Drug Halved Alzheimer’s Risk

The best evidence yet that cutting-edge Alzheimer’s disease drugs might indeed ward off the degenerative brain disease has emerged from a small-scale study. An experimental drug that clears amyloid beta from the brain cut the risk of developing Alzheimer’s by 50% among a… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., […]

Published on March 24, 2025

The Colorado Psychedelic Mushroom Experiment Has Arrived

BOULDER, Colo. — Colorado regulators are issuing licenses for providing psychedelic mushrooms and are planning to authorize the state’s first “healing centers,” where the mushrooms can be ingested under supervision, in late spring or early summer. The dawn of state-regulated psychedelic mushrooms has arrived in Colorado, nearly two years since Oregon began offering them. The […]

Published on March 24, 2025

“The Earth is Alive”: Attributing Agency to the Earth Causes Moral Concern for the Environment and Biocentric Attitudes

Abstract Do people need to attribute agency to nature to morally care for it? The answer to this question has significant implications for our understanding of social cognitive effects on moral judgment. Despite its relevance during an environmental crisis, surprisingly little is known about the answer. Across two studies, we explored whether attributing agency to […]

Published on March 23, 2025